STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2516 by analyst upside · 2026-08-13
RDNT
RadNet, Inc.
Healthcare · Market Cap $6B · P/E 0x
ANALYST PRICE TARGET
+17.4%
implied upside to consensus target
Current Price $76.95
Consensus Target $90.38
Bull Target $100.0
Bear Target $65.0
Analysts Covering 8
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
6
Hold
0
Sell
0
52-Week Low $50.82
52-Week High $85.84
YTD Return +8.5%
FUNDAMENTALS
Market Cap $6B
P/E Ratio (TTM) N/A
Forward P/E 86.8x
EPS (TTM) $-0.26
PEG Ratio 0.96
Dividend Yield N/A
Revenue (TTM) $2.3B
Profit Margin -0.9%
52-WEEK RANGE
52-Week Low $50.82
52-Week High $85.84
Current Price $76.95
Bear Target $65.0
Bull Target $100.0
● Now $76.95 ● Target $90.38
TRADING DATA
Avg Volume 843K
YTD Return +8.5%
Analyst Count 8
Consensus Buy
Upside to Target +17.4%
Last Updated 2026-08-13

ANALYST SUMMARY

RadNet, Inc. (RDNT) is currently trading at $76.95 with a Wall Street consensus price target of $90.38, implying potential upside of 17.4% over the next 12 months. 8 analysts currently cover RDNT, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $100.0, while the most cautious has a target of $65.0.

RDNT operates in the Healthcare sector with a market capitalisation of $6B. The stock is up 8.5% year-to-date and is currently trading near the upper end of its 52-week range of $50.82 – $85.84.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for RDNT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Overweight → Overweight 2026-05-20 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-04-21 Building track record
Keybanc ● Initiated
Overweight 2026-01-09 Building track record
B. Riley Securities - Reiterated
Buy → Buy 2025-12-01 17% win rate (6 calls)
Barclays - Reiterated
Overweight → Overweight 2025-11-13 Building track record
Truist Securities - Reiterated
Buy → Buy 2025-11-12 Building track record
Barclays - Reiterated
Overweight → Overweight 2025-09-03 Building track record
Truist Securities - Reiterated
Buy → Buy 2025-09-03 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
65
out of 100
Coverage depth
17/30
Consensus clarity
21/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →